An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates
Rui Zuo, Mi Wang, Y Q Wang…·Yang Zhang
This paper develops a computational platform to repurpose drugs for liver fibrosis by focusing on LSECs, identifying vorinostat and other candidates that protect LSECs.